Retzius-sparing robot-assisted radical prostatectomy: perioperative and immediate continence outcomes of an initial series

Abstract

ObjectiveThe objective of this work is to present initial perioperative, immediate continence and oncological results in a series of 25 prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy. Material and methodsWe retrospectively analyzed a series of 25 patients treated with Retzius-sparing robot-assisted radical prostatectomy for cT1–T2b prostate cancer between 2018−2019. The 5 stages of surgery are described. We make a descriptive statistic of our initial series and its outcomes in terms of immediate continence, defined as 0–1 safety pads/24 h in the first week after catheter removal. ResultsMedian follow-up, 6 months (3−18). Median PSA, 6.1 ng/mL (4−14.3). All surgeries were performed with posterior approach and 84% of the patients received intrafascial bilateral nerve-sparing. Affected surgical margins were present in 28%, being the apex the most frequent site of affectation. Surgical complications: 1 (4%) patient required transfusion of blood products in the immediate postoperative period. Mean hospital stay was 48 h. Functional results: Immediate continence is shown by 80% of the patients, and 80% of the continent patients do not require safety liner/pad. Oncological results: With a median follow-up of 6 months, 84% do not present biochemical-progression. ConclusionsInitial functional results in terms of immediate continence are very satisfactory in patients who have undergone Retzius-sparing robot-assisted radical prostatectomy without negative impact on prognosis.